The impact of crystallization conditions on structure‐based drug design: A case study on the methylene blue/acetylcholinesterase complex
Orly Dym(Weizmann Institute of Science), Israel Silman(Weizmann Institute of Science), Yacov Ashani(Weizmann Institute of Science), Robbie P. Joosten(Oncode Institute), Wanling Song(Guizhou Institute of Technology), Joel L. Sussman(Weizmann Institute of Science), Lev Weiner(Weizmann Institute of Science), Valery L. Shnyrov(Universidad de Salamanca), Esther Roth(Weizmann Institute of Science), Clifford E. Felder(Weizmann Institute of Science), Yechun Xu(Shanghai Institute of Materia Medica)
Cited by 36
Related Papers
The <i>CCP</i>4 suite: integrative software for macromolecular crystallography
|Acta Crystallographica Section D Structural Biology|2023|852
AlphaFill: enriching AlphaFold models with ligands and cofactors
|Nature Methods|2022|498